BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 3496792)

  • 21. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation.
    Böhler J; Schollmeyer P; Dressel B; Dobos G; Hörl WH
    J Am Soc Nephrol; 1996 Feb; 7(2):234-41. PubMed ID: 8785392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of the geometry of the dialyzer and the composition of the dialysate in activating the complement system.
    Miranda VM; Miranda RM; Guerra L; Magro C
    Nephron; 1990; 54(1):26-31. PubMed ID: 2296341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
    Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
    Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptoms and activation of granulocytes and complement with two dialysis membranes.
    Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
    Kidney Int; 1983 Dec; 24(6):758-63. PubMed ID: 6609268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of complement activation by hemodialysis membranes.
    Cheung AK; Henderson LW
    Am J Nephrol; 1986; 6(2):81-91. PubMed ID: 3518458
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of gamma radiation versus ethylene oxide sterilization of dialyzers and blood lines on plasma levels of granulocyte elastase in hemodialyzed patients.
    Hörl WH; Riegel W; Schollmeyer P
    Clin Nephrol; 1985 Nov; 24(5):232-6. PubMed ID: 3852707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis.
    Hörl WH; Schaefer RM; Heidland A
    Am J Nephrol; 1985; 5(5):320-6. PubMed ID: 2414989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse.
    DiRaimondo CR; Pollak VE
    Am J Kidney Dis; 1989 May; 13(5):390-5. PubMed ID: 2655439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of regional citrate anticoagulation on leukopenia, complement activation, and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes.
    Dhondt A; Vanholder R; Tielemans C; Glorieux G; Waterloos MA; De Smet R; Lameire N
    Nephron; 2000 Aug; 85(4):334-42. PubMed ID: 10940744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood flow dependent granulocyte activation in membranes with and without complement activation.
    Böhler J; Donauer J; Schollmeyer P; Hörl WH
    Adv Exp Med Biol; 1991; 297():215-24. PubMed ID: 1767753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult respiratory distress-like syndrome during hemodialysis: relationship between activation of complement, leukopenia, and release of granulocyte elastase.
    Knudsen F; Nielsen AH; Pedersen JO; Grunnet N; Jersild C
    Int J Artif Organs; 1985 Jul; 8(4):187-94. PubMed ID: 3850856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of dialyzer contaminants in the allergic epiphenomena of hemodialysis.
    Ward RA; Feldhoff PW; Klein E
    Artif Organs; 1984 Aug; 8(3):338-49. PubMed ID: 6477203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified cellulosic dialyzer membranes: an investigative tool in thrombogenicity studies.
    Mahiout A; Meinhold H; Kessel M; Vienken J; Baurmeister U
    ASAIO Trans; 1988; 34(3):878-81. PubMed ID: 3058187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatibility of artificial organs: an overview.
    Henderson LW; Chenoweth D
    Blood Purif; 1987; 5(2-3):100-11. PubMed ID: 3304344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of haemodialysis membranes on the release of granulocyte elastase.
    Irvine L; Travers M; Simpson K; Lowe GD; Courtney JM
    Int J Artif Organs; 1989 Aug; 12(8):502-4. PubMed ID: 2807595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte activation during haemodialysis in the absence of complement activation: inhibition by calcium channel blockers.
    Haag-Weber M; Schollmeyer P; Hörl WH
    Eur J Clin Invest; 1988 Aug; 18(4):380-5. PubMed ID: 3139423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory response of a new synthetic dialyzer membrane. A randomised cross-over comparison between polysulfone and helixone.
    Stefoni S; Colì L; Cianciolo G; Donati G; Ruggeri G; Ramazzotti E; Pohlmeier R; Lang D
    Int J Artif Organs; 2003 Jan; 26(1):26-32. PubMed ID: 12602466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.